Inductive Pulse Burst Treatment for Inflammation Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Sub-threshold inductive neuromodulation devices such as PEMF and LFMS struggle to reproducibly achieve a robust reduction in inflammation, with existing commercially available devices often operating outside the critical ranges for effective inflammatory response modulation.

Innovation Solution

The application of pulsed electromagnetic field (PEMF) energy with specific parameters, including a duty cycle of 4% or greater and an amplitude between 0.2 G and 1 G, is used to reduce inflammation by targeting cytokines and chemokines like TNF-α, MIP1a, IL-1β, IP-10, and MCP-1, while higher amplitude and duty cycle combinations increase inflammatory responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If PEMF devices operate outside critical parameter ranges (higher amplitude/duty cycle), then device complexity is reduced and ease of operation is improved, but the reliability of inflammatory response modulation deteriorates

Engineering Contradiction:
Improvereliability of inflammatory response modulationVSAvoidparameter control complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by precisely controlling PEMF amplitude (0.2-1.0 G) and duty cycle (4-20%) to achieve reliable anti-inflammatory effects. This resolves the contradiction by establishing specific parameter ranges that ensure consistent inflammatory response modulation while maintaining operational simplicity through standardized protocols.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If PEMF amplitude and duty cycle are increased, then ease of operation is improved, but the harmful effects increase due to increased inflammatory response

Engineering Contradiction:
Improveease of PEMF applicationVSAvoidinflammatory response
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by pre-establishing safe parameter boundaries (amplitude ≤1.0 G, duty cycle ≤20%) that prevent excessive inflammatory responses before treatment begins. This resolves the contradiction by allowing operational simplicity while preemptively avoiding harmful effects through constrained parameter selection.

Inventive Principle:
Principle #9Preliminary anti-action

3Adaptability or versatility

If sub-threshold field strengths are used to treat large tissue areas, then ease of operation is improved, but the reliability of targeting specific regions deteriorates

Engineering Contradiction:
Improvetreatment area coverageVSAvoidtarget region precision
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies local quality by using larger coils for broad coverage while maintaining precise control over electromagnetic field parameters (amplitude 0.2-1.0 G, duty cycle 4-20%) to achieve reliable anti-inflammatory effects in specific target regions. This resolves the contradiction by allowing versatile area coverage while ensuring precise therapeutic action through standardized parameter application.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a significant reduction of 20% or more in inflammatory markers, providing a robust and reliable method for modulating inflammation, and can be used to treat various inflammatory disorders and conditions, including those associated with SARS-CoV-2 infections.

Implementation Method 1

Inductive neuromodulation typically involves generating an electromagnetic field by passing current through an antenna (e.g., coil), and applying the resulting electromagnetic field to non-invasively modulate the activity of nervous system tissue adjacent to the antenna

Methodology Applied
Scientific EffectElectromagnetic induction: Electromagnetic Induction

Data Source

PatentUS20240050761A1System and methods for inductive pulse burst treatment
Publication Date: 2024.02.15 HUMANITY NEUROTECH INC
  • US20240050761A1 patent drawing
  • US20240050761A1 patent drawing
  • US20240050761A1 patent drawing

AI summary

Apparatuses and methods for delivery of pulsed electromagnetic field (PEMF) energy therapy to modulate inflammation using high-frequency current pulsed through one or more coils. For example, described herein are pulse burst waveforms, coil applicators for the head and body, and implantable biocompatible coil arrays. The methods and apparatuses described herein include parameters for PEMF energy that specifically and robustly reduce an inflammatory response. Also described herein are methods and apparatuses increasing an inflammatory response using PEMF parameters that specifically and robustly increase in inflammatory response.